Document is current

Article History

Received: 9 December 2024

Accepted: 4 May 2025

First Online: 6 August 2025

Declarations

:

: This study was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki and that are consistent with Good Clinical Practice and applicable regulatory requirements. The research protocol, interview guide, and all patient communication templates were reviewed and approved by WIRB-Copernicus Group (WCG) Institutional Review Board (IRB) prior to the study commencing (#20225959) and all patients gave written informed consent to participate.

: Not applicable.

: Joshua Maher, Stephanie Bascle, Ahmed Daak, and Sylvie Bozzi are employees and may hold stock and/or stock options in Sanofi. Anubha Shukla, Owen Cooper, Michael Kostikas and Marieke Krol are employees of IQVIA who provided research services for Sanofi for this study. Karen Jones is an employee of wAIHA Warriors. wAIHA Warriors received remuneration from IQVIA for assisting in identifying and recruiting patients with wAIHA to participate in this study. Quentin Hill provides consultancy to Alpine, Amgen, Argenx, Gliknik, Incyte, Immunovant, Janssen, Novartis, ReAlta, Sanofi and Sobi, and is speaker honoraria at Grifols and Novartis.